Nowak also shared his outlook on research in myasthenia gravis in the next 5 years.
Richard Nowak, MD, MS
Advertisement
Richard Nowak, MD, MS, associate professor of neurology, and director of Clinical & Translational Neuromuscular Research and the Yale Myasthenia Gravis Clinic at Yale School of Medicine
Articles by Richard Nowak, MD, MS
Nowak discussed some of the unique advantages inebilizumab offers for this population.
Advertisement
Latest Updated Articles
Reaching for Minimal Symptom Expression in gMG With Inebilizumab, with Richard Nowak, MD, MSPublished: June 6th 2025 | Updated:
Reducing Steroid Burden in gMG With CD19 Targeting, with Richard Nowak, MD, MSPublished: August 6th 2025 | Updated:
Advertisement
Advertisement